Incremental prognostic value of myocardial SPET with dual-isotope rest 201Tl/stress 99mTc-tetrofosmin

European Journal of Nuclear Medicine

Volumn 29, Issue 1, 2002, Pages 46-52

  Groutars, Reginald G ^a   Verzijlbergen, Fred J ^a   Zwinderman, Aeilco H ^b   Tiel Van Buul, Monique ^a   Ascoop, Carl A ^a   Van Hemel, Norbert M ^a   Van Der Wall, Ernst E ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

99mTc tetrofosmin; Dual isotope myocardial perfusion scintigraphy; Event rate; Prognostic value

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; TREATMENT INDICATION; VISION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036166617     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100653     Document Type: Article

References (17)

1. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
2. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease
3. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests
4. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease
5. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease
6. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study
7. Myocardial kinetics of radiolabeled perfusion agents: Basis for perfusion imaging
8. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease
9. m-MIBI SPET myocardial perfusion imaging
10. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study
11. Technetium 99m sestamibi in the assessment of chronic coronary artery disease
12. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification
13. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease
14. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction
15. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
16. Dual-isotope myocardial imaging: Feasibility, advantages and limitations. Preliminary report on 231 consecutive patients
17. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT